Percentage of physicians considering patients with bronchiectasis to be at particular risk of NTM infection (A) and estimated percentage of adult patients with bronchiectasis contracting NTM during the course of their disease (B)
| Country (n)* | A: Perceived risk for NTM infection | B: Estimated NTM prevalence* |
| UK | 90% (n=60) | 13% (n=47) |
| Germany | 92% (n=60) | 21% (n=44) |
| Italy | 77% (n=60) | 23% (n=40) |
| France | 87% (n=60) | 17% (n=45) |
| The Netherlands | 93% (n=40) | 12% (n=26) |
| Total | 87% (n=280) | 18% (n=202) |
*Respondents who could not estimate the risk of NTM infection in their patients were not included in this analysis.
NTM, non-tuberculous mycobacteria.